ArticleFrontiers in neurology2025
Screening and monitoring of diabetic polyneuropathy in clinical practice: present and future with connected devices.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New perspectives are opening up today in the management of diabetes thanks to the possibility of measuring, over long periods in daily life, different biomarkers likely to improve glycaemic control, such as continuous glucose monitoring and time-in-range assessment. This is part of personalized medicine. There is therefore a challenge to also benefit from specific biomarkers in the prevention and monitoring of polyneuropathy in diabetics, one of the most common type of peripheral nerve disorder worldwide. This is now possible with the development of connected tools, allowing for example to monitor at home the evolution of skin temperature or conductance at the level of the feet. In this article, the current use and recent advances in laboratory tools for the early diagnosis and objective monitoring of diabetic polyneuropathy and its progression will be presented. The follow-up of neuropathies will undoubtedly be significantly modified in clinical practice in the future, particularly in the context of diabetes, thanks to the use of connected tools and remote monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.